{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:09:53Z","timestamp":1761674993018},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.jbspin.2003.08.002","type":"journal-article","created":{"date-parts":[[2003,10,9]],"date-time":"2003-10-09T04:36:33Z","timestamp":1065674193000},"page":"465-470","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis"],"prefix":"10.1016","volume":"70","author":[{"given":"Fran\u00e7oise","family":"Debiais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2003.08.002_BIB1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","article-title":"Alendronate increases bone strength by increasing the mean degree of mineralisation of bone tissue in osteoporotic women","volume":"27","author":"Boivin","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB2","first-page":"49","article-title":"Facteurs syst\u00e9miques et locaux du remodelage osseux","author":"Marie","year":"1996"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s001980200026","article-title":"The anabolic effects of parathyroid hormone","volume":"13","author":"Rubin","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB4","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/en.142.9.4047","article-title":"Catabolic effects of continuous human PTH(1\u201338) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation","volume":"142","author":"Ma","year":"2001","journal-title":"Endocrinology"},{"issue":"Suppl","key":"10.1016\/j.jbspin.2003.08.002_BIB5","first-page":"S80","article-title":"Mechanisms of biphasic anabolic and catabolic effects of parathyroid hormone (PTH) on bone cells","volume":"28","author":"Locklin","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(76)92216-9","article-title":"Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis","volume":"I","author":"Reeve","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB8","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/bmj.280.6228.1340","article-title":"Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial","volume":"280","author":"Reeve","year":"1980","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1016\/j.jbspin.2003.08.002_BIB9","first-page":"S175","article-title":"A randomized controlled multi-center study of 1\u201384\u00a0hPTH for treatment of postmenopausal osteoporosis","volume":"23","author":"Lindsay","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB10","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/jc.85.6.2129","article-title":"Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate","volume":"85","author":"Rittmaster","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB11","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1359\/jbmr.2003.18.1.18","article-title":"The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis","volume":"18","author":"Marcus","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB13","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1210\/jc.2002-020334","article-title":"A randomised double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1\u201334)] with alendronate in postmenopausal women with osteoporosis","volume":"87","author":"Body","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","article-title":"Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis","volume":"350","author":"Lindsay","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB15","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1359\/jbmr.2001.16.5.925","article-title":"Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal","volume":"16","author":"Cosman","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"10.1016\/j.jbspin.2003.08.002_BIB16","first-page":"S137","article-title":"Parathyroid hormone 1\u201334 (hPTH1-34) and estrogen produce dramatic bone density increases in postmenopausal osteoporosis. Results from a placebo-controlled randomised trial","volume":"14","author":"Roe","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.1998.13.6.1051","article-title":"Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women","volume":"13","author":"Cosman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/8756-3282(95)00113-R","article-title":"The anabolic effect of human PTH (1\u201334) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate-Is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodelling system?","volume":"16","author":"Delmas","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1210\/jc.82.2.620","article-title":"A randomised controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis","volume":"82","author":"Hodsman","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB20","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/en.2002-221061","article-title":"New bone formation with teriparatide[human parathyroid hormone-(1\u201334)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats","volume":"144","author":"Ma","year":"2003","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"10.1016\/j.jbspin.2003.08.002_BIB21","first-page":"S157","article-title":"Early response of bone turnover markers and bone mineral density to teriparatide [recombinant human parathyroid hormone (1\u201334)] in postmenopausal women previously treated with an antiresorptive drug","volume":"17","author":"Ettinger","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"10.1016\/j.jbspin.2003.08.002_BIB22","first-page":"S200","article-title":"A clinical trial of cyclical clodronate as maintenance therapy following withdrawal of parathyroid hormone, in the treatment of post-menopausal osteoporosis","volume":"10","author":"Hodsman","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2265.1992.tb02323.x","article-title":"Treatment of osteoporosis with parathyroid peptide (hPTH1-34) and estrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone","volume":"37","author":"Bradbeer","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S8756-3282(00)00316-1","article-title":"Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2\u00a0years of cyclical hPTH (1\u201334) therapy in women with severe osteoporosis","volume":"27","author":"Hodsman","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB25","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","article-title":"Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study","volume":"16","author":"Dempster","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1359\/jbmr.2003.18.3.539","article-title":"Effects of teriparatide [recombinant human parathyroid hormone (1\u201334)] on cortical bone in post-menopausal women with osteoporosis","volume":"18","author":"Zanchetta","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1067\/mcp.2003.7","article-title":"Teriparatide has no effect on the calcium-mediated pharmacodynamics of digoxin","volume":"73","author":"Benson","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1\u201334) for 2\u00a0years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jbspin.2003.08.002_BIB29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1359\/jbmr.2003.18.1.163","article-title":"Osteosarcoma of bone in a patient with primary hyperparathyroidism: a case report","volume":"18","author":"Betancourt","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"10.1016\/j.jbspin.2003.08.002_BIB30","first-page":"S378","article-title":"Parathyroid hormone (PTH) and alendronate in the treatment of osteoporosis: PaTH trial update","volume":"17","author":"Black","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"10.1016\/j.jbspin.2003.08.002_BIB31","first-page":"S135","article-title":"Effects of parathyroid hormone, alendronate, or both on bone density in osteoporotic postmenopausal women","volume":"17","author":"Neer","year":"2002","journal-title":"J Bone Miner Res"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X03001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X03001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T15:20:58Z","timestamp":1550848858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X03001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1297319X03001805"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2003.08.002","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}